Study of Palbociclib in Combination With Binimetinib for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer
Clinical trial NCT03170206 · COMPLETED
Trial details
- NCT number
- NCT03170206
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-31
- Primary completion
- 2023-02-28
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.